DWM
TEVA icon

Dogwood Wealth Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Dogwood Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69K Sell
50
-58
-54% -$1.93K ﹤0.01% 691
2026
Q1 		$3.25K Buy
+108
New +$3.48K ﹤0.01% 561

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Dogwood Wealth Management's TEVA Position: Q2 2026 in Review

Dogwood Wealth Management reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 54% in Q2 2026, selling an estimated $1.93K and leaving 50 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #691.

Dogwood Wealth Management first reported a position in TEVA in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.25K in Q1 2026. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Dogwood Wealth Management held 50 shares of Teva Pharmaceutical Industries Limited worth $1.69K as of Q2 2026.
  • Dogwood Wealth Management sold 58 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $1.93K.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Dogwood Wealth Management's portfolio in Q2 2026, its #691 holding.
  • Dogwood Wealth Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2026 and has held it in 2 quarters since.
  • Dogwood Wealth Management's Teva Pharmaceutical Industries Limited position peaked at $3.25K in Q1 2026.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.